Literature DB >> 15176485

Gene expression profiling in fetal, aged, and Alzheimer hippocampus: a continuum of stress-related signaling.

Walter J Lukiw1.   

Abstract

While specific components of normal brain aging and Alzheimer's disease (AD) appear to be genetically determined, it is not well understood whether AD is due to accelerated aging or if AD represents an independent disease entity superimposed upon senescence. Using gene expression profiling, significant alterations in brain-specific transcription patterns have been observed between AD and age-matched controls. In AD, although a general depression in brain genetic output has been reported, there are robust increases in the expression of potentially neuropathological genes. The data in this study show increases in the RNA abundance patterns for a stress-response, proinflammatory, apoptotic, and angiogenic gene family that occur during the transition from fetal to aged, and again during the transformation from aged to AD brain. Significantly up-regulated RNAs include those encoding stress-induced factors (HSP70), transcriptional repressors (DAXX), pentraxins (SAP), proapoptosis factors (FAS and DAXX), and several inflammatory markers (betaAPP, CEX1, NF-IL6, NF-kappaBp100, cyclooxygenase-2, IL-1alpha and IL-1beta precursors and cPLA2). These findings support the hypothesis that there is a continuum of stress-related gene expression as the brain ages and an advancement of inflammatory, apoptotic, and angiogenic gene signaling that correlates with the transition to AD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15176485     DOI: 10.1023/b:nere.0000023615.89699.63

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  57 in total

Review 1.  Regulation of mRNA stability in mammalian cells.

Authors:  J Guhaniyogi; G Brewer
Journal:  Gene       Date:  2001-03-07       Impact factor: 3.688

2.  A gene expression profile of Alzheimer's disease.

Authors:  J F Loring; X Wen; J M Lee; J Seilhamer; R Somogyi
Journal:  DNA Cell Biol       Date:  2001-11       Impact factor: 3.311

Review 3.  Genetic and environmental factors in Alzheimer's disease.

Authors:  J Tol; G Roks; A J Slooter; C M van Duijn
Journal:  Rev Neurol (Paris)       Date:  1999       Impact factor: 2.607

4.  Cloning and characterization of exodus, a novel beta-chemokine.

Authors:  R Hromas; P W Gray; D Chantry; R Godiska; M Krathwohl; K Fife; G I Bell; J Takeda; S Aronica; M Gordon; S Cooper; H E Broxmeyer; M J Klemsz
Journal:  Blood       Date:  1997-05-01       Impact factor: 22.113

5.  Daxx, a novel Fas-binding protein that activates JNK and apoptosis.

Authors:  X Yang; R Khosravi-Far; H Y Chang; D Baltimore
Journal:  Cell       Date:  1997-06-27       Impact factor: 41.582

Review 6.  Serum amyloid A and high-density lipoprotein cholesterol: serum markers of inflammation in sarcoidosis and other systemic disorders.

Authors:  A Salazar; X Pintó; J Mañá
Journal:  Eur J Clin Invest       Date:  2001-12       Impact factor: 4.686

Review 7.  Alzheimer's disease and other dementias: a review.

Authors:  Shannon Rogan; Carol F Lippa
Journal:  Am J Alzheimers Dis Other Demen       Date:  2002 Jan-Feb       Impact factor: 2.035

8.  Cyclooxygenase-2 and presenilin-1 gene expression induced by interleukin-1beta and amyloid beta 42 peptide is potentiated by hypoxia in primary human neural cells.

Authors:  Nicolas G Bazan; Walter J Lukiw
Journal:  J Biol Chem       Date:  2002-06-05       Impact factor: 5.157

9.  Cerebral infarcts in patients with autopsy-proven Alzheimer's disease: CERAD, part XVIII. Consortium to Establish a Registry for Alzheimer's Disease.

Authors:  A Heyman; G G Fillenbaum; K A Welsh-Bohmer; M Gearing; S S Mirra; R C Mohs; B L Peterson; C F Pieper
Journal:  Neurology       Date:  1998-07       Impact factor: 9.910

Review 10.  Molecular mechanisms that underlie structural and functional changes at the postsynaptic membrane during synaptic plasticity.

Authors:  H V Wheal; Y Chen; J Mitchell; M Schachner; W Maerz; H Wieland; D Van Rossum; J Kirsch
Journal:  Prog Neurobiol       Date:  1998-08       Impact factor: 11.685

View more
  82 in total

1.  NF-кB-regulated micro RNAs (miRNAs) in primary human brain cells.

Authors:  Walter J Lukiw
Journal:  Exp Neurol       Date:  2011-11-23       Impact factor: 5.330

2.  Trisomy-21 gene dosage over-expression of miRNAs results in the haploinsufficiency of specific target proteins.

Authors:  Terry S Elton; Sarah E Sansom; Mickey M Martin
Journal:  RNA Biol       Date:  2010-09-01       Impact factor: 4.652

Review 3.  Regulation of complement factor H (CFH) by multiple miRNAs in Alzheimer's disease (AD) brain.

Authors:  Walter J Lukiw; Peter N Alexandrov
Journal:  Mol Neurobiol       Date:  2012-08       Impact factor: 5.590

4.  Reactive microglia drive tau pathology and contribute to the spreading of pathological tau in the brain.

Authors:  Nicole Maphis; Guixiang Xu; Olga N Kokiko-Cochran; Shanya Jiang; Astrid Cardona; Richard M Ransohoff; Bruce T Lamb; Kiran Bhaskar
Journal:  Brain       Date:  2015-03-31       Impact factor: 13.501

5.  Isolation of high spectral quality RNA using run-on gene transcription; application to gene expression profiling of human brain.

Authors:  Jian-Guo Cui; Yuhai Zhao; Walter J Lukiw
Journal:  Cell Mol Neurobiol       Date:  2005-06       Impact factor: 5.046

Review 6.  Single cell gene expression profiling in Alzheimer's disease.

Authors:  Stephen D Ginsberg; Shaoli Che; Scott E Counts; Elliott J Mufson
Journal:  NeuroRx       Date:  2006-07

7.  Age-dependent changes on TGFβ1 Smad3 pathway modify the pattern of microglial cell activation.

Authors:  Juan E Tichauer; Betsi Flores; Bernardita Soler; Laura Eugenín-von Bernhardi; Gigliola Ramírez; Rommy von Bernhardi
Journal:  Brain Behav Immun       Date:  2013-12-29       Impact factor: 7.217

Review 8.  Therapeutic implications of the prostaglandin pathway in Alzheimer's disease.

Authors:  Eiron Cudaback; Nikolas L Jorstad; Yue Yang; Thomas J Montine; C Dirk Keene
Journal:  Biochem Pharmacol       Date:  2014-01-13       Impact factor: 5.858

Review 9.  Alzheimer's disease--a dysfunction in cholesterol and lipid metabolism.

Authors:  Walter J Lukiw; Miguel Pappolla; Ricardo Palacios Pelaez; Nicolas G Bazan
Journal:  Cell Mol Neurobiol       Date:  2005-06       Impact factor: 5.046

Review 10.  Interleukins in glioblastoma pathophysiology: implications for therapy.

Authors:  Y T Yeung; K L McDonald; T Grewal; L Munoz
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.